| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner Of Rphm | Former 10% Owner Of Avrobio +3 more
10 companies
Leonard Braden Michael is a 10% Owner at Aclaris Therapeutics, Inc. with holdings across 10 companies. Recent SEC Form 4 filings include 12 buys and 8 sells.
Estimated insider holdings value: $230.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Sell | 300,000 | $4.53 | $1,359,000.00 | -2.1% | - | - | |
| Oct 3, 2025 | ASTC Astrotech Corp | 10% Owner | Sell | 229,576 | $7.08 | $1,625,071.29 | -100% | -37.9% | - | |
| May 30, 2025 | ANTX An2 Therapeutics, Inc. | 10% Owner | Sell | 2,532,000 | $1.13 | $2,872,476.80 | -15.5% | +3.8% | - | |
| May 28, 2025 | ANTX An2 Therapeutics, Inc. | 10% Owner | Sell | 200,000 | $1.09 | $218,000.00 | -6.2% | 0.0% | - | |
| Sep 25, 2024 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Buy | 98,346 | $1.47 | $144,737.75 | +1.5% | -48.4% | -83.4% | |
| Sep 18, 2024 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Buy | 56,106 | $1.36 | $76,236.86 | +0.8% | -41.8% | -83.5% | |
| Sep 16, 2024 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Buy | 358,923 | $1.35 | $484,344.09 | +4.0% | -33.7% | -82.7% | |
| Aug 14, 2024 | ANTX An2 Therapeutics, Inc. | 10% Owner | Buy | 1,500,000 | $1.04 | $1,560,000.00 | +35.3% | +1.0% | +0.5% | |
| Aug 14, 2024 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Buy | 271,826 | $1.40 | $380,597.79 | +4.9% | +17.6% | -81.8% | |
| Aug 5, 2024 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 373,569 | $1.27 | $472,756.74 | +1.3% | +75.0% | +25.0% |